AIM ImmunoTech Inc.
AIM- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946644
In the last 90 days, AIM ImmunoTech Inc. insiders filed 4 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $325.6K in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding AIM ImmunoTech Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 13 | 1 | 18 | +6 |
| Shares | 106.0K | 17.5K | 175.8K | +87.3K (+98.6%) |
| Value | $119.8K | $19.8K | $102.8K | +$2.84K (+2.8%) |
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held AIM ImmunoTech Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 50,895 | $30.0K | 0.00% |
| HRT Financial LP | 26,032 | $15.0K | 0.00% |
| XTX Topco Ltd | 20,590 | $12.0K | 0.00% |
| Jane Street Group, LLC | 20,047 | $11.7K | 0.00% |
| Vanguard Fiduciary Trust Co | 17,519 | $10.2K | 0.00% |
| GWM Advisors LLC | 5,000 | $2.92K | 0.00% |
| Harbour Investments, Inc. | 32 | $19 | 0.00% |
| Creative Financial Designs Inc | 30 | $18 | 0.00% |
Sold out (2)
Institutions that held AIM ImmunoTech Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| DRW Securities, LLC | 69,545 | $78.6K |
| Bank of America Corp | 28 | $32 |
Not filed for Q1 2026 yet (1)
Institutions that held AIM ImmunoTech Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 17,502 | $19.8K |